The accuracy of flexible spectral imaging colour enhancement for the diagnosis of gastric intestinal metaplasia: Do we still need histology to select individuals at risk for adenocarcinoma?

European Journal of Gastroenterology and Hepatology

Volumn 26, Issue 7, 2014, Pages 704-709

  Kikuste, Ilze ^a,b   Stirna, Dans ^b   Liepniece Karele, Inta ^d   Leja, Marcis ^a,b,c   Dinis Ribeiro, Mário ^e,f  

^a UNIVERSITY OF LATVIA   (Latvia)

^b Digestive Diseases Centre GASTRO   (Australia)

^c RIGA EAST UNIVERSITY HOSPITAL   (Latvia)

^d Academic Histology Laboratory SIA   (Latvia)

^e University of Porto   (Portugal)

^f PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

Author keywords

Diagnostic accuracy; Flexible spectral imaging colour enhancement; Gastric adenocarcinoma; Intestinal metaplasia

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FLEXIBLE GASTROSCOPE; FLEXIBLE SPECTRAL IMAGING COLOUR ENHANCEMENT; GOLD STANDARD; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE ENDOSCOPY; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; STOMACH ADENOCARCINOMA; STOMACH BIOPSY; STOMACH MUCOSA; ADENOCARCINOMA; BIOPSY; CLINICAL TRIAL; COLORIMETRY; GASTROSCOPY; IMAGE ENHANCEMENT; METAPLASIA; MIDDLE AGED; PATHOLOGY; PRECANCER; PROCEDURES; REPRODUCIBILITY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STANDARDS; STOMACH TUMOR; VALIDATION STUDY; VERY ELDERLY;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; BIOPSY; COLORIMETRY; FEMALE; GASTRIC MUCOSA; GASTROSCOPY; HUMANS; IMAGE ENHANCEMENT; MALE; METAPLASIA; MIDDLE AGED; PRECANCEROUS CONDITIONS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STOMACH NEOPLASMS;

EID: 84902183382     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0000000000000108     Document Type: Article

References (18)

1. Dinis-Ribeiro M, Areia M, de Vries AC, Marcos-Pinto R, Monteiro-Soares M, O'Connor A, et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy 2012; 44:74-94.
2. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process-First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992; 52:6735-6740.
3. Kikuste I, Marques-Pereira R, Monteiro-Soares M, Pimentel-Nunes P, Areia M, Leja M, Dinis-Ribeiro M. Systematic review of the diagnosis of gastric premalignant conditions and neoplasia with high-resolution endoscopic technologies. Scand J Gastroenterol 2013; 48:1108-1117.
4. Tahara T, Shibata T, Nakamura M, Yoshioka D, Okubo M, Arisawa T, Hirata I. Gastric mucosal pattern by using magnifying narrow-band imaging endoscopy clearly distinguishes histological and serological severity of chronic gastritis. Gastrointest Endosc 2009; 70:246-253.
5. Bansal A, Ulusarac O, Mathur S, Sharma P. Correlation between narrow band imaging and nonneoplastic gastric pathology: a pilot feasibility trial. Gastrointest Endosc 2008; 67:210-216.
6. Uedo N, Ishihara R, Iishi H, Yamamoto S, Yamamoto S, Yamada T, et al. A new method of diagnosing gastric intestinal metaplasia: narrow-band imaging with magnifying endoscopy. Endoscopy 2006; 38:819-824.
7. Dutta AK, Sajith KG, Pulimood AB, Chacko A. Narrow band imaging versus white light gastroscopy in detecting potentially premalignant gastric lesions: a randomized prospective crossover study. Indian J Gastroenterol 2013; 32:37-42.
8. Rerknimitr R, Imraporn B, Klaikeaw N, Ridtitid W, Jutaghokiat S, Ponauthai Y, et al. Non-sequential narrow band imaging for targeted biopsy and monitoring of gastric intestinal metaplasia. World J Gastroenterol 2011; 17:1336-1342.
9. Savarino E, Corbo M, Dulbecco P, Gemignani L, Giambruno E, Mastracci L, et al. Narrow-band imaging with magnifying endoscopy is accurate for detecting gastric intestinal metaplasia. World J Gastroenterol 2013; 19:2668-2675.
10. Capelle LG, Haringsma J, de Vries AC, Steyerberg EW, Biermann K, van Dekken H, Kuipers EJ. Narrow band imaging for the detection of gastric intestinal metaplasia and dysplasia during surveillance endoscopy. Dig Dis Sci 2010; 55:3442-3448.
11. Pimentel-Nunes P, Dinis-Ribeiro M, Soares JB, Marcos-Pinto R, Santos C, Rolanda C, et al. A multicenter validation of an endoscopic classification with narrow band imaging for gastric precancerous and cancerous lesions. Endoscopy 2012; 44:236-246.
12. Guo YT, Li YQ, Yu T, Zhang TG, Zhang JN, Liu H, et al. Diagnosis of gastric intestinal metaplasia with confocal laser endomicroscopy in vivo: a prospective study. Endoscopy 2008; 40:547-553.
13. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20:1161-1181.
14. Capelle LG, de Vries AC, Haringsma J, Ter Borg F, de Vries RA, Bruno MJ, et al. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest Endosc 2010; 71:1150-1158.
15. Walker MM. Is intestinal metaplasia of the stomach reversible? Gut 2003; 52:1-4.
16. Pittayanon R, Rerknimitr R, Wisedopas N, Ridtitid W, Kongkam P, Treeprasertsuk S, et al. Flexible spectral imaging color enhancement plus probe-based confocal laser endomicroscopy for gastric intestinal metaplasia detection. J Gastroenterol Hepatol 2013; 28:1004-1009.
17. O'Connor A, McNamara D, O'Morain CA. Surveillance of gastric intestinal metaplasia for the prevention of gastric cancer. Cochrane Database Syst Rev 2013; 9:CD009322.
18. Hyun YS, Han DS, Bae JH, Park HS, Eun CS. Interobserver variability and accuracy of high-definition endoscopic diagnosis for gastric intestinal metaplasia among experienced and inexperienced endoscopists. J Korean Med Sci 2013; 28:744-749.